Latest Breaking News On - Drug inspections - Page 2 : comparemela.com

<b> Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved </b> <br/> <b>Expanding Portfolio with New Drug Innovations and Strategic R&amp;D Partnerships </b><b/> <br/> <br/> HONG KONG SAR - EQS Newswire - 27 March 2023 - A fully integrated biopharmaceutical company – <b>Uni-Bio Science Group Limited</b> ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2022 (the "Year").

Kingsley leungDotbio pteChina centerAlliance procurementBio science group limited uniBio science groupCell penetration protein alternation technology ceChina national medical products administrationGroup acarbose tablets boshutaiGroup bogutaiAlephoson biopharmaceuticals ltdRecord high turnoverHigh turnoverProfit achievedNew drug innovationsStrategic rd partnerships